333 related articles for article (PubMed ID: 34309913)
41. First-trimester pre-eclampsia biomarker profiles in Asian population: multicenter cohort study.
Chaemsaithong P; Sahota D; Pooh RK; Zheng M; Ma R; Chaiyasit N; Koide K; Shaw SW; Seshadri S; Choolani M; Panchalee T; Yapan P; Sim WS; Sekizawa A; Hu Y; Shiozaki A; Saito S; Leung TY; Poon LC
Ultrasound Obstet Gynecol; 2020 Aug; 56(2):206-214. PubMed ID: 31671479
[TBL] [Abstract][Full Text] [Related]
42. Estimated fetal weight at mid-gestation in prediction of pre-eclampsia in singleton pregnancy.
Frei L; Wright A; Syngelaki A; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2022 Mar; 59(3):335-341. PubMed ID: 34860455
[TBL] [Abstract][Full Text] [Related]
43. Serum PlGF compared with PAPP-A in first trimester screening for preterm pre-eclampsia: Adjusting for the effect of aspirin treatment.
Wright D; Tan MY; O'Gorman N; Syngelaki A; Nicolaides KH
BJOG; 2022 Jul; 129(8):1308-1317. PubMed ID: 35015330
[TBL] [Abstract][Full Text] [Related]
44. sFlt-1/PlGF for prediction of early-onset pre-eclampsia: STEPS (Study of Early Pre-eclampsia in Spain).
Perales A; Delgado JL; de la Calle M; García-Hernández JA; Escudero AI; Campillos JM; Sarabia MD; Laíz B; Duque M; Navarro M; Calmarza P; Hund M; Álvarez FV;
Ultrasound Obstet Gynecol; 2017 Sep; 50(3):373-382. PubMed ID: 27883242
[TBL] [Abstract][Full Text] [Related]
45. Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting.
Zeisler H; Llurba E; Chantraine FJ; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Schoedl M; Grill S; Hund M; Verlohren S
Ultrasound Obstet Gynecol; 2019 Mar; 53(3):367-375. PubMed ID: 30014562
[TBL] [Abstract][Full Text] [Related]
46. Maternal vascular indices at 36 weeks' gestation in the prediction of preeclampsia.
Mansukhani T; Wright A; Arechvo A; Lamanna B; Menezes M; Nicolaides KH; Charakida M
Am J Obstet Gynecol; 2024 Apr; 230(4):448.e1-448.e15. PubMed ID: 37778678
[TBL] [Abstract][Full Text] [Related]
47. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.
Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A
J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492
[TBL] [Abstract][Full Text] [Related]
48. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE.
Tan MY; Wright D; Syngelaki A; Akolekar R; Cicero S; Janga D; Singh M; Greco E; Wright A; Maclagan K; Poon LC; Nicolaides KH
Ultrasound Obstet Gynecol; 2018 Jun; 51(6):743-750. PubMed ID: 29536574
[TBL] [Abstract][Full Text] [Related]
49. Uterine artery Doppler and sFlt-1/PlGF ratio: prognostic value in early-onset pre-eclampsia.
Gómez-Arriaga PI; Herraiz I; López-Jiménez EA; Escribano D; Denk B; Galindo A
Ultrasound Obstet Gynecol; 2014 May; 43(5):525-32. PubMed ID: 24185845
[TBL] [Abstract][Full Text] [Related]
50. Performance of first-trimester combined screening for preterm pre-eclampsia: findings from cohort of 10 110 pregnancies in Spain.
Cuenca-Gómez D; de Paco Matallana C; Rolle V; Valiño N; Revello R; Adiego B; Mendoza M; Molina FS; Carrillo MP; Delgado JL; Wright A; Santacruz B; Gil MM
Ultrasound Obstet Gynecol; 2023 Oct; 62(4):522-530. PubMed ID: 37099759
[TBL] [Abstract][Full Text] [Related]
51. Placental growth factor and fetoplacental Doppler indices in combination predict preterm birth reliably in pregnancies complicated by fetal growth restriction.
Hong J; Crawford K; Cavanagh E; da Silva Costa F; Kumar S
Ultrasound Obstet Gynecol; 2024 May; 63(5):635-643. PubMed ID: 37820083
[TBL] [Abstract][Full Text] [Related]
52. ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis.
Shen L; Martinez-Portilla RJ; Rolnik DL; Poon LC
Ultrasound Obstet Gynecol; 2021 Oct; 58(4):546-552. PubMed ID: 33998099
[TBL] [Abstract][Full Text] [Related]
53. Role of sFlt-1/PlGF ratio and feto-maternal Doppler for the prediction of adverse perinatal outcome in late-onset pre-eclampsia.
Graupner O; Karge A; Flechsenhar S; Seiler A; Haller B; Ortiz JU; Lobmaier SM; Axt-Fliedner R; Enzensberger C; Abel K; Kuschel B
Arch Gynecol Obstet; 2020 Feb; 301(2):375-385. PubMed ID: 31734756
[TBL] [Abstract][Full Text] [Related]
54. Screening for pre-eclampsia using sFlt-1/PlGF ratio cut-off of 38 at 30-37 weeks' gestation.
Dragan I; Georgiou T; Prodan N; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2017 Jan; 49(1):73-77. PubMed ID: 27619203
[TBL] [Abstract][Full Text] [Related]
55. Impaired placentation in women with chronic hypertension who develop pre-eclampsia.
Panaitescu AM; Akolekar R; Kametas N; Syngelaki A; Nicolaides KH
Ultrasound Obstet Gynecol; 2017 Oct; 50(4):496-500. PubMed ID: 28470791
[TBL] [Abstract][Full Text] [Related]
56. Prediction using serum glycosylated fibronectin of imminent pre-eclampsia in women with new-onset hypertension.
Sokratous N; Bednorz M; Wright A; Nicolaides KH; Kametas NA
Ultrasound Obstet Gynecol; 2023 Nov; 62(5):653-659. PubMed ID: 37606310
[TBL] [Abstract][Full Text] [Related]
57. Routine first-trimester combined screening for pre-eclampsia: pregnancy-associated plasma protein-A or placental growth factor?
Noël L; Guy GP; Jones S; Forenc K; Buck E; Papageorghiou AT; Thilaganathan B
Ultrasound Obstet Gynecol; 2021 Oct; 58(4):540-545. PubMed ID: 33998078
[TBL] [Abstract][Full Text] [Related]
58. Role of placental, fetal and maternal cardiovascular markers in predicting adverse outcome in women with suspected or confirmed pre-eclampsia.
Reddy M; Palmer K; Rolnik DL; Wallace EM; Mol BW; Da Silva Costa F
Ultrasound Obstet Gynecol; 2022 May; 59(5):596-605. PubMed ID: 34985800
[TBL] [Abstract][Full Text] [Related]
59. Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population.
Chaemsaithong P; Pooh RK; Zheng M; Ma R; Chaiyasit N; Tokunaka M; Shaw SW; Seshadri S; Choolani M; Wataganara T; Yeo GSH; Wright A; Leung WC; Sekizawa A; Hu Y; Naruse K; Saito S; Sahota D; Leung TY; Poon LC
Am J Obstet Gynecol; 2019 Dec; 221(6):650.e1-650.e16. PubMed ID: 31589866
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of angiogenic factors in prediction of growth-related neonatal morbidity at term and comparison with competing-risks model.
Papastefanou I; Nobile Recalde A; Silva Souza Y; Syngelaki A; Nicolaides KH
Ultrasound Obstet Gynecol; 2024 Apr; 63(4):457-465. PubMed ID: 37963283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
